Advanced search
Publication Cover
Cancer Investigation Volume 26, 2008 - Issue 1
Submit an article Journal homepage
123
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Biologic Markers of Angiogenesis: Circulating Endothelial Cells in Patients with Advanced Malignancies Treated on Phase I Protocol with Metronomic Chemotherapy and Celecoxib

Przemyslaw W. Twardowski Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
,
Leslie Smith-Powell Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
,
Mary Carroll Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
,
J. VanBalgooy Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
,
Christopher Ruel Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California, USA
,
Paul Frankel Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California, USA
&
Timothy W. Synold Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
 show all
Pages 53-59 | Published online: 11 Jun 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

David P Samuel, Patrick Y Wen & Mark W Kieran. (2009) Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. Expert Opinion on Investigational Drugs 18:7, pages 973-983.
Read now

Articles from other publishers (20)

Vijay M. Patil, Vanita Noronha, Amit Joshi, Sachin Dhumal, Manoj Mahimkar, Atanu Bhattacharjee, Vikram Gota, Manish Pandey, Nandini Menon, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Kavita Nawale, Sadaf Mukadam, Bhavin Solanki, Sudeep Das, Vijai Simha, George Abraham, Arun Chandrasekharan, Vikas Talreja, Hollis DSouza, Sujay Srinivas, Lakhan Kashyap, Shripad Banavali & Kumar Prabhash. (2019) Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer. Journal of Clinical Oncology 37:32, pages 3032-3041.
Crossref
David M. Vail, Douglas H. Thamm & Julias M. Liptak. 2019. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology 251 285 .
M. R. Custead, H.Y. Weng & M. O. Childress. (2017) Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer. Veterinary and Comparative Oncology 15:3, pages 808-819.
Crossref
Antonio Gnoni, Nicola Silvestris, Antonella Licchetta, Daniele Santini, Mario Scartozzi, Roberto Ria, Salvatore Pisconti, Fausto Petrelli, Angelo Vacca & Vito Lorusso. (2015) Metronomic chemotherapy from rationale to clinical studies: A dream or reality?. Critical Reviews in Oncology/Hematology 95:1, pages 46-61.
Crossref
Aaron J. Smith, John Oertle & Dino Prato. (2015) Novel Approach to Chemotherapy and Administration Selection with Metronomic/Fractionated Dosing. Journal of Cancer Therapy 06:05, pages 455-465.
Crossref
Mohamed I. NounouFatema ElAmrawyNada AhmedKamilia AbdelraoufSatyanarayana GodaHussaini Syed-Sha-Qhattal. (2015) Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer: Basic and Clinical Research 9s2, pages BCBCR.S29420.
Crossref
Keemo Delos Santos, Kelly Lien, Soley Georgsdottir, Lavarnan Sivanathan & Urban Emmenegger. 2014. Metronomic Chemotherapy. Metronomic Chemotherapy 263 279 .
Adriana Romiti, M. Christina Cox, Ida Sarcina, Roberta Di Rocco, Chiara D?Antonio, Viola Barucca & Paolo Marchetti. (2013) Metronomic chemotherapy for cancer treatment: a decade of clinical studies. Cancer Chemotherapy and Pharmacology 72:1, pages 13-33.
Crossref
. 2013. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology 215 244 .
Nicolas Penel, Antoine Adenis & Guido Bocci. (2012) Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?. Critical Reviews in Oncology/Hematology 82:1, pages 40-50.
Crossref
Zineb Benbrahim, Christophe Massard & Omar El Mesbahi. (2011) Chimiothérapie métronomique en 2011 : actualités et perspectives. Bulletin du Cancer 98:12, pages 1447-1454.
Crossref
Katherine N. Weilbaecher, Theresa A. Guise & Laurie K. McCauley. (2011) Cancer to bone: a fatal attraction. Nature Reviews Cancer 11:6, pages 411-425.
Crossref
David A. Reardon, Annick Desjardins, Katherine Peters, Sridharan Gururangan, John Sampson, Jeremy N. Rich, Roger McLendon, James E. HerndonIIII, Jennifer Marcello, Stevie Threatt, Allan H. Friedman, James J. Vredenburgh & Henry S. Friedman. (2010) Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. Journal of Neuro-Oncology 103:2, pages 371-379.
Crossref
William Cruz-Munoz, Giulio Francia & Robert S. Kerbel. 2012. Cancer Metastasis. Cancer Metastasis 573 586 .
K Brookes, J Cummings, A Backen, A Greystoke, T Ward, G C Jayson & C Dive. (2010) Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. British Journal of Cancer 102:10, pages 1524-1532.
Crossref
Antoine Italiano, Maud Toulmonde, Barbara Lortal, Eberhard Stoeckle, Delphine Garbay, Guy Kantor, Michèle Kind, Jean-Michel Coindre & Binh Bui. (2010) “Metronomic” chemotherapy in advanced soft tissue sarcomas. Cancer Chemotherapy and Pharmacology 66:1, pages 197-202.
Crossref
D A Reardon, A Desjardins, J J Vredenburgh, S Gururangan, J H Sampson, S Sathornsumetee, R E McLendon, J E Herndon, J E Marcello, J Norfleet, A H Friedman, D D Bigner & H S Friedman. (2009) Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. British Journal of Cancer 101:12, pages 1986-1994.
Crossref
Andrea Fontana, Luca Galli, Anna Fioravanti, Paola Orlandi, Costanza Galli, Lorenza Landi, Simona Bursi, Giacomo Allegrini, Eloise Fontana, Roberta Di Marsico, Andrea Antonuzzo, Manolo D'Arcangelo, Romano Danesi, Mario Del Tacca, Alfredo Falcone & Guido Bocci. (2009) Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer. Clinical Cancer Research 15:15, pages 4954-4962.
Crossref
Balazs Dome, Jozsef Timar, Andrea Ladanyi, Sandor Paku, Ferenc Renyi-Vamos, Walter Klepetko, Gyorgy Lang, Peter Dome, Krisztina Bogos & Jozsef Tovari. (2009) Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy. Critical Reviews in Oncology/Hematology 69:2, pages 108-124.
Crossref
Nicolas André, Angelique Rome, Carole Coze, Laetitia Padovani, Eddy Pasquier, Laurence Camoin & Jean Claude Gentet. (2008) Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: A preliminary monocentric study. Clinical Therapeutics 30:7, pages 1336-1340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.